New release spotlight: KingFisher Apex system targets higher-throughput sample prep

Thermo Fisher Scientific’s KingFisher Apex Purification System is positioned as a high-throughput, automated sample preparation platform for labs that need consistent nucleic acid, protein and cell isolation. The Tuesday launch focus: where the Apex fits and what sets it apart from earlier KingFisher models.

Edited by ad hoc news New Releases & Launches Desk. Reviewed before publication on 06/16/2026 at 5:20 AM ET. Details in the imprint.

Thermo Fisher Scientific is pushing deeper into automated sample preparation with its KingFisher Apex Purification System, a benchtop instrument designed to handle up to 24 samples in parallel for nucleic acid, protein and cell isolation workflows. The system, part of the long-running KingFisher magnetic-particle processing line, is pitched at clinical, biopharma and research labs that need higher throughput than manual prep without moving to fully integrated, floor-standing robots. According to Thermo Fisher, Apex runs pre-programmed protocols, supports a broad chemistry portfolio and is aimed at delivering consistent yields with minimal hands-on time for scientists who routinely process dozens of samples per day. The official product page describes supported applications from DNA/RNA extraction to protein purification.

What the KingFisher Apex system is designed to do

At its core, the KingFisher Apex is a magnetic-particle processor that automates binding, washing and elution steps in 96-well plates or deep-well formats, using disposable tip combs to transfer magnetic beads between wells. Thermo Fisher specifies that Apex can process up to 24 samples per run, and the instrument’s deck accommodates a range of plate types to support different kit chemistries for viral RNA, genomic DNA, plasmid DNA, proteins and cells. The platform is intended to work with Thermo Fisher’s own MagMAX nucleic acid isolation kits as well as other compatible magnetic-bead reagents, which allows labs to standardize sample prep across different downstream assays such as real-time PCR, digital PCR and sequencing.

The company highlights several usability changes compared with earlier KingFisher models, including a touchscreen interface, on-board protocol storage and the ability to control runs through Thermo Scientific BindIt software. This software environment lets users select pre-validated protocols or customize parameters like mixing speeds, incubation times and wash steps, which can be important for fine-tuning yields and purity in complex matrices such as serum or environmental samples. By decoupling sample preparation from downstream instruments, Apex is positioned as a flexible front-end platform that can serve multiple analyzers in the same lab, from qPCR cyclers to next-generation sequencers. Thermo Fisher also points to reduced manual pipetting and standardized workflows as contributors to lower variability between runs, an issue that often complicates multi-site or longitudinal studies.

Throughput and walk-away time remain key metrics in this category, and the Apex system is positioned between low-throughput manual prep and fully automated integrated systems. In many labs, an instrument that prepares 24 samples per run with pre-programmed scripts can free staff from repetitive pipetting, enabling technicians to focus on data analysis, method development or more complex assays while Apex handles routine extractions. For labs that run multiple workflows, the ability to swap plate types and chemistries on the same instrument can also help maximize utilization of bench space and capital budgets, especially as testing menus expand in areas like oncology, infectious disease and pharmacogenomics.

Thermo Fisher’s broader automated sample preparation portfolio, including the KingFisher Flex and the higher-capacity KingFisher Presto, suggests the company is segmenting its line by throughput, deck configuration and integration options. Apex fits as a mid-range system aimed at labs that want higher throughput than basic magnetic-rack workflows but do not yet require robotic arms, conveyor systems or fully integrated diagnostic platforms. In that sense, Thermo Fisher is aiming the Apex at a large installed base of molecular labs that have outgrown manual extraction but still value a compact footprint and stand-alone configuration. The company emphasizes compatibility with a range of validated protocols, which can help labs meet regulatory and quality-management requirements when running clinical or regulated assays. A Thermo Fisher brochure outlines validated workflows for workflows such as viral RNA extraction for respiratory testing.

Pricing for KingFisher Apex varies by configuration, bundled kits and regional programs, and Thermo Fisher does not publish a list price on its US web page for the system. Instead, the company typically quotes pricing through direct sales representatives or distributors, often combining instrument purchases with reagent supply agreements or promotional financing for qualified labs. In the US, the Apex system is marketed directly by Thermo Fisher Scientific and through selected channel partners, with lead times depending on demand, service coverage and regional logistics. For labs evaluating automation options, considerations will likely include not only the acquisition price but also ongoing reagent costs, service contracts and the potential to redeploy staff from manual extraction tasks to higher-value work.

KingFisher Apex’s positioning comes at a time when many clinical and research labs are balancing fluctuating testing volumes with staff shortages and a growing menu of molecular assays. Automation of the sample preparation step, which often accounts for a disproportionate share of hands-on time and potential error, can be one lever to stabilize turnaround times and data quality. For labs that already use Thermo Fisher instruments for downstream analysis, such as Applied Biosystems real-time PCR systems or Ion Torrent sequencers, an Apex installation can also centralize procurement around a single supplier, which some institutions value for consolidated service and support. However, competing solutions from other life-science tool providers mean that features like protocol flexibility, integration options and total cost of ownership will likely be scrutinized closely by purchasing committees and lab directors.

Within Thermo Fisher’s portfolio, automated sample preparation platforms such as KingFisher Apex support recurring reagent revenue streams and help lock in long-term customer relationships in molecular diagnostics, biopharma development and academic research. These instruments can also serve as anchor points for broader workflow sales, from upstream sample collection kits to downstream analytical platforms and informatics offerings, strengthening Thermo Fisher’s role as a full-workflow provider rather than a single-instrument vendor. According to recent market coverage, Thermo Fisher is viewed by many analysts as a key supplier of "tools behind the breakthroughs" in life sciences. Shares of Thermo Fisher Scientific (ISIN US8835561023) traded on the NYSE at around $575 on 06/13/2026.

KingFisher Apex Purification System in brief

• Product: KingFisher Apex Purification System
• Manufacturer: Thermo Fisher Scientific Inc.
• Category: New Release - Automated sample preparation system
• Launch date: 2020 (global market introduction, regionally phased)
• MSRP / Price: Not publicly listed; typically quoted via Thermo Fisher sales channels
• Availability: Sold directly by Thermo Fisher and authorized distributors in key markets including the US, Europe and Asia-Pacific
• Target audience: Clinical, biopharma, public health and research laboratories needing mid-throughput automated nucleic acid, protein and cell isolation
• Key differentiator / USP: Automated magnetic-particle sample preparation for up to 24 samples per run, with flexible protocols and support for a broad range of nucleic acid and protein purification kits in a compact benchtop design

This article was a.i.-assisted and editorially reviewed. Product information without warranty; prices and availability may change at short notice. Not investment advice and not a buy or sell recommendation. Trading involves risk up to and including the total loss of invested capital.